Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector
Open Access
- 11 March 2015
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 26 (5) , 312-319
Abstract
Neointima formation and vascular remodeling through vascular smooth muscle cell migration and proliferation can limit the long-term success of coronary interventions, for example, in coronary artery bypass grafting (CABG). Ex vivo gene therapy has the potential to reduce unnecessary cell proliferation and limit neointima formation in vascular pathologies. To date, the species C adenovirus serotype 5 has been commonly used for preclinical gene therapy; however, its suitability is potentially limited by relatively poor tropism for vascular cells and high levels of preexisting immunity in the population. To avoid these limitations, novel species of adenovirus are being tested; here we investigate the potential of adenovirus 49 (Ad49) for use in gene therapy. Transduction of primary human vascular cells by a range of adenovirus serotypes was assessed; Ad49 demonstrated highest transduction of both vascular smooth muscle and endothelial cells. Gene transfer with Ad49 in vascular smooth muscle and endothelial cells was possible following short exposure times (Ex vivo delivery to surplus CABG tissue showed efficient gene transfer with Ad49, consistent with the in vitro findings. Luminal infusion of Ad49GFP into intact CABG samples ex vivo resulted in efficient vessel transduction. In addition, no seroprevalence rates to Ad49 were observed in a Scottish cohort of patients from cardiovascular clinics, thus circumventing issues with preexisting immunity. Our results show that Ad49 has tropism for vascular cells in vitro and ex vivo and demonstrate that Ad49 may be an improved vector for local vascular gene therapy compared with current alternatives.Keywords
This publication has 48 references indexed in Scilit:
- Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profileJournal of Cardiothoracic Surgery, 2013
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- AAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical OpportunitiesMolecular Therapy, 2011
- Human Studies of Angiogenic Gene TherapyCirculation Research, 2009
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical TrialJournal of Cardiac Failure, 2009
- Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene TransferJournal of Virology, 2009
- Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitroExperimental Cell Research, 2009
- Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and DJournal of Virology, 2007
- Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan AfricaJournal of Clinical Microbiology, 2006
- Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanismGene Therapy, 2005